202 related articles for article (PubMed ID: 29652784)
1. A Prospective, Randomized, Multicenter Study Comparing Silicated Calcium Phosphate versus BMP-2 Synthetic Bone Graft in Posterolateral Instrumented Lumbar Fusion for Degenerative Spinal Disorders.
Coughlan M; Davies M; Mostert AK; Nanda D; Willems PC; Rosenberg G; Ferch R
Spine (Phila Pa 1976); 2018 Aug; 43(15):E860-E868. PubMed ID: 29652784
[TBL] [Abstract][Full Text] [Related]
2. Evaluation of an increased strut porosity silicate-substituted calcium phosphate, SiCaP EP, as a synthetic bone graft substitute in spinal fusion surgery: a prospective, open-label study.
Bolger C; Jones D; Czop S
Eur Spine J; 2019 Jul; 28(7):1733-1742. PubMed ID: 30834972
[TBL] [Abstract][Full Text] [Related]
3. A prospective, randomized, controlled trial comparing radiographic and clinical outcomes between stand-alone lateral interbody lumbar fusion with either silicate calcium phosphate or rh-BMP2.
Pimenta L; Marchi L; Oliveira L; Coutinho E; Amaral R
J Neurol Surg A Cent Eur Neurosurg; 2013 Nov; 74(6):343-50. PubMed ID: 23444134
[TBL] [Abstract][Full Text] [Related]
4. [Adjacent segment degeneration after lumbosacral fusion in spondylolisthesis: a retrospective radiological and clinical analysis].
Zencica P; Chaloupka R; Hladíková J; Krbec M
Acta Chir Orthop Traumatol Cech; 2010 Apr; 77(2):124-30. PubMed ID: 20447355
[TBL] [Abstract][Full Text] [Related]
5. Efficacy of Escherichia coli-derived recombinant human bone morphogenetic protein-2 in posterolateral lumbar fusion: an open, active-controlled, randomized, multicenter trial.
Cho JH; Lee JH; Yeom JS; Chang BS; Yang JJ; Koo KH; Hwang CJ; Lee KB; Kim HJ; Lee CK; Kim H; Suk KS; Nam WD; Han J
Spine J; 2017 Dec; 17(12):1866-1874. PubMed ID: 28652196
[TBL] [Abstract][Full Text] [Related]
6. Clinical Outcomes of Posterolateral Fusion vs. Posterior Lumbar Interbody Fusion in Patients with Lumbar Spinal Stenosis and Degenerative Instability.
Farrokhi MR; Yadollahikhales G; Gholami M; Mousavi SR; Mesbahi AR; Asadi-Pooya AA
Pain Physician; 2018 Jul; 21(4):383-406. PubMed ID: 30045595
[TBL] [Abstract][Full Text] [Related]
7. Clinical outcomes and fusion success at 2 years of single-level instrumented posterolateral fusions with recombinant human bone morphogenetic protein-2/compression resistant matrix versus iliac crest bone graft.
Dimar JR; Glassman SD; Burkus KJ; Carreon LY
Spine (Phila Pa 1976); 2006 Oct; 31(22):2534-9; discussion 2540. PubMed ID: 17047540
[TBL] [Abstract][Full Text] [Related]
8. Clinical outcomes of 3 fusion methods through the posterior approach in the lumbar spine.
Kim KT; Lee SH; Lee YH; Bae SC; Suk KS
Spine (Phila Pa 1976); 2006 May; 31(12):1351-7; discussion 1358. PubMed ID: 16721298
[TBL] [Abstract][Full Text] [Related]
9. Randomized clinical trial: expanded autologous bone marrow mesenchymal cells combined with allogeneic bone tissue, compared with autologous iliac crest graft in lumbar fusion surgery.
García de Frutos A; González-Tartière P; Coll Bonet R; Ubierna Garcés MT; Del Arco Churruca A; Rivas García A; Matamalas Adrover A; Saló Bru G; Velazquez JJ; Vila-Canet G; García-Lopez J; Vives J; Codinach M; Rodriguez L; Bagó Granell J; Càceres Palou E
Spine J; 2020 Dec; 20(12):1899-1910. PubMed ID: 32730985
[TBL] [Abstract][Full Text] [Related]
10. Bone morphogenetic protein-2 and bone marrow aspirate with allograft as alternatives to autograft in instrumented revision posterolateral lumbar spinal fusion: a minimum two-year follow-up study.
Taghavi CE; Lee KB; Keorochana G; Tzeng ST; Yoo JH; Wang JC
Spine (Phila Pa 1976); 2010 May; 35(11):1144-50. PubMed ID: 20139805
[TBL] [Abstract][Full Text] [Related]
11. Single-level instrumented posterolateral fusion of lumbar spine with beta-tricalcium phosphate versus autograft: a prospective, randomized study with 3-year follow-up.
Dai LY; Jiang LS
Spine (Phila Pa 1976); 2008 May; 33(12):1299-304. PubMed ID: 18496340
[TBL] [Abstract][Full Text] [Related]
12. Posterior lumbar interbody fusion versus posterolateral fusion in adult isthmic spondylolisthesis.
Ekman P; Möller H; Tullberg T; Neumann P; Hedlund R
Spine (Phila Pa 1976); 2007 Sep; 32(20):2178-83. PubMed ID: 17873808
[TBL] [Abstract][Full Text] [Related]
13. Clinical outcomes and fusion rates following anterior lumbar interbody fusion with bone graft substitute i-FACTOR, an anorganic bone matrix/P-15 composite.
Mobbs RJ; Maharaj M; Rao PJ
J Neurosurg Spine; 2014 Dec; 21(6):867-76. PubMed ID: 25325176
[TBL] [Abstract][Full Text] [Related]
14. A pilot study evaluating the safety and efficacy of OP-1 Putty (rhBMP-7) as a replacement for iliac crest autograft in posterolateral lumbar arthrodesis for degenerative spondylolisthesis.
Vaccaro AR; Patel T; Fischgrund J; Anderson DG; Truumees E; Herkowitz HN; Phillips F; Hilibrand A; Albert TJ; Wetzel T; McCulloch JA
Spine (Phila Pa 1976); 2004 Sep; 29(17):1885-92. PubMed ID: 15534410
[TBL] [Abstract][Full Text] [Related]
15. Fusion rate of Escherichia coli-derived recombinant human bone morphogenetic protein-2 compared with local bone autograft in posterior lumbar interbody fusion for degenerative lumbar disorders.
Park S; Jeong YH; Ha BJ; Yoo BS; Kim SH; Lee CK; Yi S; Ha Y; Kim KN; Shin DA
Spine J; 2023 Dec; 23(12):1877-1885. PubMed ID: 37516282
[TBL] [Abstract][Full Text] [Related]
16. Clinical outcomes of lumbar degenerative disc disease treated with posterior lumbar interbody fusion allograft spacer: a prospective, multicenter trial with 2-year follow-up.
Arnold PM; Robbins S; Paullus W; Faust S; Holt R; McGuire R
Am J Orthop (Belle Mead NJ); 2009 Jul; 38(7):E115-22. PubMed ID: 19714280
[TBL] [Abstract][Full Text] [Related]
17. Risk factors of adjacent segment disease requiring surgery after lumbar spinal fusion: comparison of posterior lumbar interbody fusion and posterolateral fusion.
Lee JC; Kim Y; Soh JW; Shin BJ
Spine (Phila Pa 1976); 2014 Mar; 39(5):E339-45. PubMed ID: 24365899
[TBL] [Abstract][Full Text] [Related]
18. Guideline update for the performance of fusion procedures for degenerative disease of the lumbar spine. Part 11: interbody techniques for lumbar fusion.
Mummaneni PV; Dhall SS; Eck JC; Groff MW; Ghogawala Z; Watters WC; Dailey AT; Resnick DK; Choudhri TF; Sharan A; Wang JC; Kaiser MG
J Neurosurg Spine; 2014 Jul; 21(1):67-74. PubMed ID: 24980588
[TBL] [Abstract][Full Text] [Related]
19. Transforaminal lumbar interbody fusion with rhBMP-2 in spinal deformity, spondylolisthesis, and degenerative disease--part 1: Large series diagnosis related outcomes and complications with 2- to 9-year follow-up.
Crandall DG; Revella J; Patterson J; Huish E; Chang M; McLemore R
Spine (Phila Pa 1976); 2013 Jun; 38(13):1128-36. PubMed ID: 23370679
[TBL] [Abstract][Full Text] [Related]
20. Use of recombinant human bone morphogenetic protein-2 to achieve posterolateral lumbar spine fusion in humans: a prospective, randomized clinical pilot trial: 2002 Volvo Award in clinical studies.
Boden SD; Kang J; Sandhu H; Heller JG
Spine (Phila Pa 1976); 2002 Dec; 27(23):2662-73. PubMed ID: 12461392
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
